Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
Enter Symbol
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
93M
Market Cap:
$0.47B
Avg Volume:
160156
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Opinion and Analysis
Petrobras Puts And Calls In Play As Shares Drop After Q4 Earnings
Feb 05, 2013 02:25 PM |
PBR
,
PLX
Protalix Biotherapeutics (PLX) Signs Clinical Development Agreement With Pfizer (PFE) For Gaucher Disease
Dec 06, 2012 09:07 AM |
PFE
,
PLX
Pfizer (PFE), Protalix (PLX) Say EC Refuses Marketing Authorization for Gaucher Disease Therapy
Nov 01, 2012 11:06 AM |
PFE
,
PLX
More Articles on PLX..
Press Releases
Protalix BioTherapeutics and Brazil's Ministry of Health Enter Into Supply and Technology Transfer Agreement for UPLYSO(TM) (alfataliglicerase) in Brazil
Jun 19, 2013 02:00 AM |
PLX
Protalix BioTherapeutics to Host Analyst Event in New York City
Jun 12, 2013 07:30 AM |
PLX
Protalix BioTherapeutics to Present at the Oppenheimer 14th Annual Israeli Conference
May 08, 2013 07:30 AM |
PLX
More Press Releases on PLX..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
PLX
Compare to S&P
YTD
-4.05 %
-15.88 %
4 Weeks
-3.49 %
-1.07 %
12 Weeks
-10.11 %
-13.97 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
54.55 %
EPS Growth in Last Year:
28.57 %
Sales Growth in Last Quarter:
204.44 %
Sales Growth in Last Quarter:
-7.59 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##